CORPORATE NEWS
NEWSROOM
-
Recent Corporate News
-
2010 Corporate News
Dec. 2, 2010 Merck to Acquire SMarchCells, Inc. Nov. 30, 2010 Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman Nov. 23, 2010 Merck Announces First-Quarter 2011 Dividend Nov. 19, 2010 Merck Wins Another Federal FOSAMAX® (alendronate sodium) Bellwether Trial Nov. 9, 2010 Merck Wins TEMODAR® Patent Infringement Lawsuit on Appeal Oct. 28, 2010 Statement on FOSAMAX® (alendronate sodium) Product Liability Trial in U.S. District Court Oct. 13, 2010 Weight Watchers and Merck Collaborate to Help Physicians Fight Obesity Through Lifestyle Management Approach Oct. 13, 2010 Tenth Edition of The Merck Veterinary Manual Debuts Oct. 12, 2010 Lundbeck and Merck Sign Exclusive Commercialization Agreement for SYCREST® (asenapine) Sublingual Tablets in All Marchets Outside of the United States, China and Japan Oct. 04, 2010 Merck to Appeal Reduced Jury Verdict in Federal FOSAMAX® (alendronate sodium) Case Sept. 30, 2010 Merck to Appeal Verdict in Massachusetts Medicaid Case Sept. 29, 2010 Why So Shy? What Females of the Facebook Generation Are Not Sharing in the OB/GYN Office that Could Affect Their Health Sept. 22, 2010 Merck Significantly Expands its Patient Assistance Program Offerings to Provide Access to More Medicines for People in Need Aug. 10, 2010 Black AIDS Institute, in Partnership with Merck, Launches Dynamic National HIV/AIDS Treatment and Care Advocacy Network July 27, 2010 Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to Hepatitis C Therapy July 27, 2010 Sanofi-aventis and Merck Appoint Raul Kohan as CEO for the New Animal Health Joint Venture July 27, 2010 Sinopharm and Merck Sign Statement of Mutual Intent July 08, 2010 Merck Details Plans to Advance Integration of R&D, Manufacturing and Business Operations Worldwide June 29, 2010 Merck Wins Case Filed by Louisiana Attorney General Involving VIOXX® June 25, 2010 Merck Challenges Verdict in Federal FOSAMAX® (alendronate sodium) Trial Aug. 10, 2010 Black AIDS Institute, in Partnership with Merck, Launches Dynamic National HIV/AIDS Treatment and Care Advocacy Network June 24, 2010 Merck to Expand Business in South Africa June 21, 2010 Merck and Codexis Honored with Presidential Green Chemistry Challenge Award for Novel Process for Sitagliptin Synthesis June 7, 2010 Statement on FOSAMAX® (alendronate sodium) Product Liability Trial in U.S. District Court May 10, 2010 Merck Settles Patent Infringement Case for Zetia® (ezetimibe)
The information contained in each news release posted on this page was factually accurate on the date it was issued. The company assumes no duty to update the information to reflect subsequent developments. Readers of the news releases should not rely upon the information as current or accurate after their issuance dates.
-
Patients & Caregivers
-
Healthcare Professionals
-
Media & Investors
-
Job Seekers
-
Company Statements
- Copyright © 2009-2012 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
- Privacy
- Terms of Use
- Site Map
